Alan R. Katz to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Alan R. Katz has written about Neoplasm Recurrence, Local.
Connection Strength
0.371
-
Bates JE, Choi G, Usuki KY, Katz AW, Milano MT. Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy. Am J Clin Oncol. 2018 12; 41(12):1172-1175.
Score: 0.158
-
Milano MT, Katz AW, Okunieff P. Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ. Am J Clin Oncol. 2010 Apr; 33(2):157-63.
Score: 0.086
-
Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. JAMA Netw Open. 2019 02 01; 2(2):e188006.
Score: 0.040
-
Berber B, Ibarra R, Snyder L, Yao M, Fabien J, Milano MT, Katz AW, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria J. Multicentre results of stereotactic body radiotherapy for secondary liver tumours. HPB (Oxford). 2013 Nov; 15(11):851-7.
Score: 0.026
-
Sisler JJ, Seo B, Katz A, Shu E, Chateau D, Czaykowski P, Wirtzfeld D, Singh H, Turner D, Martens P. Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis. J Oncol Pract. 2012 Jul; 8(4):e69-79.
Score: 0.025
-
Milano MT, Chen Y, Katz AW, Philip A, Schell MC, Okunieff P. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Radiother Oncol. 2009 Jun; 91(3):301-6.
Score: 0.020
-
Carey Sampson M, Katz A, Constine LS. Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol. 2006 Apr; 16(2):67-76.
Score: 0.016